IP Library › Granted Patent US 10,653,348
Granted Patent B2
US 10,653,348 · App. 15/682,412 · Granted May 19, 2020

Foot pulse oximeter for screening congenital heart disease before newborn discharge

Inventors: Ruey-Kang Chang (Diamond Bar, CA); Yann Ping Pan (Diamond Bar, CA)
Assignee: LOS ANGELES BIOMEDICAL RESEARCH INSTITUTE AT HARBOR-UCLA MEDICAL CENTER
A61B5/14552A61B5/02438A61B5/6829
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,653,348
App. No.
15/682,412
Granted
May 19, 2020
Kind
B2
Abstract

A method including placing a portion of a foot of a newborn in a device, the device including a light emitter and a corresponding receiver coupled on opposite sides of the device, the device further including a processor for processing data from the light emitter and receiver; and determining a presence of congenital heart disease. An apparatus including a body including a chamber of a size to accommodate a portion of a newborn's foot; at least one light emitter and a corresponding detector coupled on opposite sides of the body, the emitter configured to emit light of a prescribed wavelength into the chamber; and a processor coupled to the body and configured to receive a signal from the at least one detector.

Claims (33)

1. A method comprising:

placing a portion of a foot of a newborn in a device, the device comprising;

a light emitter and a corresponding receiver coupled on opposite sides of the device,

a processor for processing data from the light emitter and receiver;

a chamber configured to receive the portion of the foot of the newborn, and

a cover configured to be inserted into the chamber and form a double layer structure with the chamber, the cover configured to cover the portion of the foot of the newborn when the portion of the foot of the newborn is in the chamber,

wherein placing the portion of the newborn's foot in the device comprises placing the cover into the chamber, and placing the portion of the newborn's foot into the cover, such that the cover covers the portion of the newborn's foot within the chamber, and

wherein the cover comprises translucent areas and non-translucent areas, locations of the translucent areas positioned to correspond to positions of the light emitter and the receiver, and

determining a presence of congenital heart disease in the newborn based on the data from the light emitter and receiver.

2. The method of claim 1 , wherein the device comprises three or more light emitter/receiver pairs, and the cover comprises additional corresponding translucent areas positioned to correspond to the light emitters and receivers in the three or more light emitter/receiver pairs, the method further comprising detecting one or more best quality signals from the three or more light emitter/receiver pairs for the newborn's foot for display and analysis.

3. The method of claim 2 , wherein the light emitter/receiver pairs are positioned on the device to detect signals from a dorsalis pedis artery at a first toe of the foot of the newborn or from a plantar arch artery.

4. The method of claim 2 , wherein the device further comprises a power button and a display on the device.

5. The method of claim 4 , wherein the display displays SpO 2 , heart rate and arterial pulse waveforms in response to the data from the light emitter and the receiver.

6. The method of claim 1 , wherein the processor comprises an algorithm configured to determine a signal quality of a signal from the receiver, to process the data from the light emitter and receiver in the signal, and display SpO 2 , heart rate and waveform results on a display of the device.

7. The method of claim 1 , further comprising indicating on the device the determination of the presence of congenital heart disease.

8. The method of claim 7 , wherein determining the presence of congenital heart disease comprises determining an arterial saturation of hemoglobin (SpO 2 ).

9. The method of claim 8 , further comprising indicating the presence of congenital heart disease when the SpO 2 is equal to or lower than a predetermined threshold.

10. The method of claim 9 , wherein the SpO 2 predetermined threshold is 94 percent.

11. The method of claim 8 , wherein the SpO 2 predetermined threshold can be configured by a user.

12. The method of claim 2 , wherein the one or more best quality signals are selected from among a larger number of signals from external and/or internal receivers.

13. An apparatus comprising:

a body comprising a chamber of a size to accommodate a portion of a newborn's foot;

a cover configured to be inserted into the chamber and form a double layer structure with the chamber, the cover configured to cover the portion of the newborn's foot when the portion of the newborn's foot is in the chamber;

at least one light emitter and a corresponding detector coupled on opposite sides of the body, the emitter configured to emit light of a prescribed wavelength into the chamber; wherein the cover comprises translucent areas and non-translucent areas, locations of the translucent areas positioned to correspond to positions of the light emitter and detector, and

and

a processor coupled to the body and configured to receive a signal from the detector, and determine a presence of congenital heart disease in the newborn based on data in the signal from the detector.

14. The apparatus of claim 13 , further comprising three or more light emitter/detector pairs, wherein the cover comprises additional corresponding translucent areas positioned to correspond to the light emitters and detectors in the three or more light emitter/detector pairs, and wherein the processor is configured to detect one or more best quality signals from the emitter/detector pairs for the newborn's foot for display and analysis.

15. The apparatus of claim 14 , wherein the light emitter/detector pairs are positioned on the body to detect signals from a dorsalis pedis artery at a first toe of the foot or from a plantar arch artery.

16. The apparatus of claim 13 , further comprising a display coupled to the body.

17. The apparatus of claim 16 , wherein the display displays SpO 2 , heart rate and arterial pulse waveforms in response to data produced by the light emitter and the detector.

18. The apparatus of claim 16 , wherein the processor comprises an algorithm configured to determine a signal quality of a signal from the detector, to process data from the light emitter and the detector in the signal, and display at least one of SpO 2 , heart rate and a waveform result on the display.

19. The apparatus of claim 17 , further comprising at least one indicator light on the body, wherein the processor is configured to cause the indicator to indicate a presence of congenital heart disease based on data the processor processes from the at least one emitter and corresponding detector.

20. The system of claim 14 , wherein the one or more best quality signals are selected from among a larger number of signals from external and/or internal detectors.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 21, 2017
From: CHANG, RUEY-KANG; PAN, YANN PING
To: LOS ANGELES BIOMEDICAL RESEARCH INSTITUTE AT HARBOR-UCLA MEDICAL CENTER
Reel/Frame 043348/0944 →
Continuity (3)
Continuation 13216150 · Aug 23, 2011
Provisional Application 61375875 · Aug 23, 2010
Related Publication 20170347931A1 · Dec 7, 2017